NEDD4L knockdown could increase the protein level of glutamate transporters and rescue the motor deficits and tyrosine hydroxylase expression in PD mice, suggesting that NEDD4L could be a potential therapeutic target for the treatment of PD (Zhang et al., 2017). This evidence concerns the gene TH and Parkinson disease.